FDA
approval
· 2026-04-06
FDA Approved: DAPAGLIFLOZIN AND SAXAGLIPTIN — Original Application (Novadoz Pharmaceuticals LLC)
Summary
FDA approved the original application for a generic fixed-dose combination of dapagliflozin and saxagliptin, manufactured by Novadoz Pharmaceuticals LLC. The pr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DAPAGLIFLOZIN AND SAXAGLIPTIN (DAPAGLIFLOZIN AND SAXAGLIPTIN)